Additionally, cGAMP induces the upregulation of PD-L1 expression in the HCC and enhances the response of anti-PD-L1 Nb and the escape blockade of immune checkpoint PD-1/PD-L1 for amplified immunotherapy of HCC. Here, CD274 is linked to hepatocellular carcinoma.